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Abstract
Objective Patient question-asking is essential to shared decision
making. We sought to describe patients’ questions when faced with
cancer prevention and screening decisions, and to explore diﬀerences
in question-asking as a function of health literacy with respect to
spoken information (health literacy–listening).
Methods Four-hundred and thirty-three (433) adults listened to sim-
ulated physician–patient interactions discussing (i) prophylactic
tamoxifen for breast cancer prevention, (ii) PSA testing for prostate
cancer and (iii) colorectal cancer screening, and identiﬁed questions
they would have. Health literacy–listening was assessed using the
Cancer Message Literacy Test-Listening (CMLT-Listening). Two
authors developed a coding scheme, which was applied to all ques-
tions. Analyses examined whether participants scoring above or
below the median on the CMLT-Listening asked a similar variety of
questions.
Results Questions were coded into six major function categories:
risks/beneﬁts, procedure details, personalizing information, addi-
tional information, decision making and credibility. Participants
who scored higher on the CMLT-Listening asked a greater variety
of risks/beneﬁts questions; those who scored lower asked a greater
variety of questions seeking to personalize information. This diﬀer-
ence persisted after adjusting for education.
Conclusion Patients’ health literacy–listening is associated with dis-
tinctive patterns of question utilization following cancer screening
and prevention counselling. Providers should not only be responsive
to the question functions the patient favours, but also seek to ensure
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that the patient is exposed to the full range of information needed
for shared decision making.
Introduction
Patient engagement, deﬁned as patient involve-
ment in actions needed to obtain the greatest
beneﬁt from available health-care services,1 is a
key component of patient-centred care and an
important determinant of health status and
outcomes.2–4 Rather than passively receiving
health-care prescriptions and recommendations,
engaged patients make aﬃrmative eﬀorts to seek
out health information and use that information
to make decisions.5 Active involvement in dis-
cussions with physicians is one mark of patient
engagement. This element of engagement with
one’s provider requires patients to exercise
health literacy, which in turn is linked to positive
health outcomes.6,7
There is considerable overlap between patient
engagement activities and the health behaviour
patterns ascribed to patients who have high
levels of health literacy.8 A landmark Institute
of Medicine report deﬁned health literacy as
including the capacity to obtain and understand
both printed and spoken health information,
and to apply that information to make health-
related decisions.9 Recent conceptualizations of
health literacy continue to recognize the central
role of oral processing,10–12 and reviews of
research linking health literacy to appropriate
utilization of health services and positive health
outcomes have decried the fact that most health
literacy research has relied on assessments of
print literacy only.13,14
We have proposed that the capacity to ask
questions of physicians (and other health infor-
mation sources) is a function of ‘interactive
health literacy’, that is the kind of health literacy
engaged patients enact when they talk with their
providers.15 Patient question-asking in clinical
encounters is crucial, and is linked to greater
comprehension of treatment options16 and to
greater information provision by physicians.17
Limited evidence also suggests an association
between patient question-asking and outcomes
such as chronic disease self-management.18
Campaigns have been developed enjoining
patients to become more active questioners,19 and
considerable eﬀort has been devoted to interven-
tions to increase patient question-asking, but with
mixed results so far.20–23 Patients facing decisions
involving unfamiliar procedures may need to ask
questions to clarify those aspects of the decision
which matter most to them, as physicians may
not provide complete information.24 Patient
question-asking is also critical when the complex-
ity of relevant information about the beneﬁts,
harms and uncertainties associated with the avail-
able options makes decision making even more
challenging.25 Such complexity may cause both
physicians26 and patients27 to forego providing
and seeking relevant information and to diminish
their engagement in shared decision making.
Relatively little is known about patients’ capac-
ity for eﬀective question-asking in cancer
screening and prevention,28 or about the relation-
ship between patient question-asking in clinical
encounters and patients’ ability to understand
spoken health information. The ability to
understand spoken health information is a key
component of health literacy, which we refer to
as health literacy–listening. The recent develop-
ment of an instrument to measure comprehension
of spoken information about cancer prevention
and screening, the Cancer Message Literacy Test-
Listening (CMLT-Listening),29,30 has enabled
new research in this area.
The purpose of this study was to examine ques-
tion-asking during decision making about cancer
screening and prevention. Of particular interest
was the relationship between question-asking and
health literacy–listening. While there is some
evidence that patients with lower health literacy
reading skills tend to ask fewer questions,31,32 we
were unable to identify any studies examining
whether question-asking varies for patients at dif-
ferent levels of health literacy-listening skills, an
aspect of health literacy expected to be more
closely related to question-asking. Speciﬁcally, we
sought to describe the types of questions that
analogue patients asked following three simu-
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lated discussions, and to explore the relationship
between health literacy and the variety of
questions generated.
Methods
Study population and setting
This study was conducted in the context of the
HMO Cancer Research Network (CRN), which
consists of the research programmes, enrollee
populations and databases of 14 member organi-
zations comprising the HMOResearch Network.
The CRN’s overall goal is to conduct collabora-
tive research to determine the eﬀectiveness of
preventive, curative and supportive interventions
for major cancers among diverse populations
and health systems. The CRN is funded by the
National Cancer Institute (U19 CA 079689).
This study was nested within a parent study
focused on the development and psychometric
evaluation of a test to assess health literacy with
respect to spoken information (health literacy-
listening). For the parent study, recruitment
targeted a stratiﬁed random sample of adult
health plan members who had been enrolled for at
least 5 years and were aged 40–70. This age range
was chosen because of the increased likelihood
that patients in this age range would face decisions
about cancer prevention and screening, and the
fact that cancer risk increases with age. Sampling
strata were deﬁned on geocoded United States
Census-based estimates of educational level; at
one site, in Atlanta, Georgia, sampling was
further stratiﬁed to ensure that African American
and white members were invited in equal numbers
within each educational strata. A variety of
recruitment methods were used including mail-
ings, telephone follow-up and oﬀering study
sessions at multiple locations. The invitations
described the study as focusing on communica-
tion, including physician–patient communication.
A cash incentive was provided. Interested mem-
bers were screened to conﬁrm the ability to
communicate in English, adequate corrected hear-
ing and vision, and the absence of any physical or
psychological limitations that would interfere
with participation. A total of 1074 participants
completed interviews in the ﬁrst round of data
collection from 22 June 2009 to 19April 2010.
For the second round of data collection, 789
participants from the parent study were invited
to return to complete a second study session.
Invitees were drawn from three health plans:
Kaiser Permanente Georgia (KPGA) Atlanta,
GA, Kaiser Permanente Hawaii (KPHI) Hono-
lulu, HI, and Fallon Community Health Plan
(FCHP) Worcester, MA. One site participating
in the parent study did not participate in the
second round of data collection due to funding
constraints. As in the ﬁrst round of data collec-
tion, recruitment eﬀorts included mail and
telephone invitations, reference to physician–
patient communication and a cash incentive.
Interviews for the second round of data collec-
tion occurred between 04 August 2011 and 27
January 2012 and lasted approximately 1–1.5 h.
All participants provided written informed
consent prior to participation in each study
session and were able to withdraw at any time.
Data collection
All study sessions were conducted in-person by
trained research staﬀ, with oversight from the
principal investigator at the study site. Interview-
ers were provided detailed written instructions,
and the online data collection programme
(REDCap)33 included the interview text for ref-
erence during the interview.
Assessment of health literacy–listening
During the ﬁrst round of data collection, partici-
pants completed the Cancer Message Literacy
Test-Listening (CMLT- Listening) which ass-
esses comprehension of spoken health messages
related to cancer prevention and screening. This
test has strong psychometric properties (e.g.
coeﬃcient alpha = 0.83) and validity evi-
dence.29,30 Health literacy is most often
conceived as a stable trait of patients and con-
sumers,34 contingent in large measure on socio-
economic status, and unlikely to change over
time without deliberate intervention or by modi-
fying the health-care system.35
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Physician–patient vignettes to stimulate
question-asking
Data in this study were elicited by three cancer-
related audio-vignettes, developed to stimulate
question-asking. The vignettes portrayed physi-
cian–patient discussions about three clinical
situations and were created by the study team,
which included three physicians. The situations
were as follows: (i) consideration of tamoxifen for
primary prevention of breast cancer in women at
elevated risk, (ii) discussion of prostate-speciﬁc
antigen (PSA) testing, and (iii) recommendation
for colorectal cancer (CRC) screening, with a
description of faecal occult blood test (FOBT)
and colonoscopy as screening options. Due to the
nature of the decision being discussed, the infor-
mation provided by the physician diﬀered across
the vignettes; vignette duration ranged from
2 min, 27 sec to 5 min 11 sec. Both men and
women listened and responded to all three clinical
situations. Multiple versions of each vignette were
created to portray subtle variations in certain
physician communication patterns (e.g. whether
the physician repeated the main points). Those
variations resulted in no diﬀerences in relevant
outcomes, and these versions were therefore
ignored for this analysis. Study materials
(vignette texts and print materials) are available
upon request from the ﬁrst author.
Vignette order was randomized for each par-
ticipant. After listening to each vignette,
participants were asked the following: ‘Imagine
the doctor is sitting here with us. What questions
would you have for him?’ Participants, function-
ing as analogue patients as is common in
patient–provider research,36,37 could oﬀer as
many questions as they liked, but were
prompted for up to three questions. Responses
were transcribed verbatim.
Content analysis of participants’ questions
Two authors (DLR and KMM) reviewed a sam-
ple of participants’ questions and developed
preliminary content coding categories. They then
reviewed additional questions and independently
applied the preliminary codes. Discrepancies
were discussed, coding categories were reﬁned,
and additional questions were reviewed and
coded in an iterative fashion until they agreed
that the coding categories were suﬃciently
deﬁned and captured the relevant elements of
participants’ questions.
Questions were coded into major categories
reﬂecting six question functions: (i) assessing
risks and beneﬁts, (ii) asking for details of proce-
dures, (iii) asking how the information applied
to one’s personal situation, (iv) asking for addi-
tional information beyond the information the
doctor introduced in the vignette discourse, (v)
asking about the locus of decision making and
(vi) establishing the credibility of the physician
or other sources (See Table 1). These six func-
tions were arrived at by a combination of a
priori reasoning and inductive methods. For
example, the a priori rationale for the personaliz-
ing function is that a key component of health
literacy is not just to acquire information, but to
be able to act on information to make personal
health decisions.38 In contrast, the function
asking for details about the procedures was estab-
lished inductively from the numerous instances
of participants asking about what they would
experience if they underwent the procedure or
began preventive treatment. This coding scheme
emerged quite similar to one used in an earlier
study of CRC screening conversations.24
The six question-function categories are each
comprised of several subcategories reﬂecting dis-
crete constituent question types or subfunctions.
Thus, for example, in the tamoxifen vignette,
questions that personalize information can fall
into six possible question types or subfunctions
(e.g. personal risk of negative side-eﬀects: ‘What
are my personal risks of experiencing negative
side-eﬀects from tamoxifen?’ Or, personal degree
of protection against breast cancer: ‘In my indi-
vidual case, what is the likelihood that
tamoxifen would be able to reduce my chances
of getting breast cancer?’). Likewise, in the CRC
screening vignette, six question types comprise
the risk/beneﬁt function (e.g. accuracy/sensitiv-
ity of the various screening techniques: ‘Does
the other test [FOBT] ﬁnd polyps like colono-
scopy can?’ Or, discomforts of CRC screening:
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‘Does that laxative have side-eﬀects?’). Due to
diﬀerences in the content of the three vignettes
(e.g. the CRC vignette posed the choice between
two diﬀerent screening tests, the PSA vignette
focused on just one), the total number of con-
stituent question subfunctions varied. The
coding scheme for tamoxifen contained 22 ques-
tion subfunctions distributed across the six
functions; PSA had 24 question subfunctions,
and CRC screening 29. The complete coding
scheme is available from the ﬁrst author.
When the coding scheme was ﬁnalized, a
research assistant (RA) was trained in the cod-
ing system. The RA and one author (DR)
independently coded a sample of at least 10% of
the responses within each of the three vignettes
to check coding consistency. Discrepancies were
discussed, and double coding of responses
continued until coding consistency (exact match
in assigning question types for each response)
exceeded 80%. The RA then coded the remain-
ing responses. Because many participants’
responses were diﬃcult to parse into syntacti-
cally delineated questions, we did not compute
the number of questions asked. Rather, each
response was coded for the presence or absence
of each of the constituent question subtypes.
Repetitions of question subfunctions within a
response to a vignette were not recorded. All
participant utterances in response to the probe,
‘What questions would you have?’, were consid-
ered in this coding system, irrespective of their
grammatical form. We adopted this approach to
avoid confounding our outcome (question-
function variety) with the particular linguistic
forms in which participants framed their infor-
mation seeking. For similar reasons, the
dependent variables reﬂect whether a patient
used a particular question function rather than
how frequently she or he used it.
Statistical analyses
First, to summarize the variety of question func-
tions used, we computed a variable reﬂecting
whether the participant asked any questions
under each of the six functions across the three
vignettes. For instance, if a participant asked
one or more questions in the personalization
function category in the tamoxifen vignette, one
or more questions in the risk/beneﬁt function
category in the PSA and CRC vignette, and no
other questions under any of the other four func-
tions, the participant would be assigned a score
of two on this variable.
Second, using the number of subfunction
codes within each function used across the three
vignettes, we computed the percentage used of
the total number available as a measure of ques-
tion variety within function. For example, if a
participant asked a question about the risk of
breast cancer, another about how one might
reduce the likelihood of tamoxifen side-eﬀects,
no questions related to risks or beneﬁts of PSA
testing, and a question about the beneﬁts of
polyp removal during colonoscopy, the number
of risk/beneﬁts subfunction codes applied across
Table 1 Question-function categories and descriptions
Question-function
category
Brief description and
exemplary subfunctions
Risks and benefits Asking about costs and benefits
of treatment or screening;
includes questions about test
accuracy, dangers of procedures,
side-effects of treatment, survival
rates and prognosis
Details of the
procedures
Asking for additional information,
greater detail or clarification of what
treatment or screening procedure is
actually like; what one would have
to do to comply
Applying information
to one’s personal
situation
Asking how the information applies
to oneself, or bringing in one’s own
prior knowledge and asking how
that applies
Information external
to the doctor’s
discourse
Asking for new or additional
information that goes beyond what
was introduced in the vignette; for
instance, questions about
alternatives
Locus and timing
of decision making
Asking what the doctor recommends,
for additional information
(e.g. books) to inform the decision,
or about postponing the decision
Source credibility Asking about the physician’s
expertise or experience, asking
about credibility of the science or
the role of pharma
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the three vignettes would be four of a possible 14
risk/beneﬁt subfunction codes available, result-
ing in a percentage of 28.6. We also computed
the total number of subfunction codes utilized
across all functions and vignettes (theoretic
range, 0–75).
We used the median CMLT-Listening score to
split the sample into two groups, referred to
here as high CMLT-Listening and low CMLT-
Listening. Thus, in this study the designations
‘high’ and ‘low’ are relative terms rather than a
criterion-based classiﬁcation based on a pre-
determined cut score. We used t-tests to examine
the relationship between health literacy and
variety in question-asking. If we detected a signif-
icant eﬀect, we also used linear regression
models, adjusting for level of education, to assess
whether the relationship between question variety
and CMLT-Listening was still present after tak-
ing education into account. Education was
considered the most important potential modera-
tor to investigate, as measured health literacy
often covaries with years of schooling.39 Finally,
we used a chi-squared statistic to examine
whether participants scoring high or low on the
CMLT-Listening diﬀered in whether they had
asked any questions. To examine whether the
ﬁndings depended on the speciﬁc cut score used,
we repeated all analyses comparing those scoring
in the bottom quartile on the CMLT-Listening to
those scoring in the top three quartiles.
Because two of the vignettes contained gen-
der-speciﬁc clinical content, we also examined
the eﬀects of gender. We ﬁrst tested for gender-
related diﬀerences in CMLT-Listening scores
using t-tests. We then compared question variety
overall, and within each question function (e.g.
risk/beneﬁt), again using t-tests. We also com-
puted the percentage of women and men asking
questions within each function and subfunction
by vignette type.
This study was reviewed and approved by the
Institutional Review Board at each site.
Results
A total of 433 adults participated in the present
study and provided usable responses for these
analyses. Participant characteristics are pre-
sented in Table 2. The mean CMLT-Listening
score for this sample was 79.9, and the standard
deviation (SD) was 14.1; scores ranged from
33.3 to 100, with a median of 84.4. We found no
statistically signiﬁcant gender-related diﬀerences
in mean CMLT-Listening scores (P > 0.05).
Examples of participants’ questions, grouped
by function and vignette, are presented in
Table 3. Table 3 includes descriptive data show-
ing the frequency of utilization of each question
function for the three cancer vignettes and over-
all, the entire sample, and separately for women
and men. For example, a substantial majority of
participants overall (70%) asked at least one
risk/beneﬁt question; the corresponding percent-
ages for women and men were 68% and
73%, respectively.
We found no diﬀerence in question variety as
deﬁned by the total number of diﬀerent question
functions used by health literacy level. The med-
ian was three for both groups (P > 0.05); the
mean for participants scoring below the median
on the CMLT-Listening test was 3.06 function
Table 2 Participant characteristics
Characteristic n Percent
Total sample 433 100.0
Gender
Female 245 56.6
Male 188 43.4
Age in years
40–49 73 16.9
50–59 158 36.5
60+ 202 46.7
Race/ethnicity
Black/African American 63 14.7
Asian/Native Hawaiian/Pacific Islander 47 10.9
White/Caucasian 277 64.6
Hispanic 15 3.5
American Indian/Alaskan Native 4 0.9
Multiple races 20 4.6
Not reported 3 0.7
Education
≤ High school or trade school 102 23.7
Some college–graduate school 328 76.3
CMLT-Listening Score (Mean, SD) 433 79.9 (14.1)
Self-rated health
Good/fair/poor 194 44.9
Excellent/very good 238 55.1
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Table 3 Question-function usage and illustrative quotes by vignette
Function
Risk/Benefits
70% of participants asked at least one risk/benefit question (Women: 68%; Men: 73%)
Clinical Situation
Examples
Tamoxifen – 46% of participants asked at least one risk/benefit question following the tamoxifen vignette.
(Women: 42%; Men: 51%)
I probably would like to know more specifics about the percentages of side effects; he gave the
percentage of risk reduction via the tamoxifen, 50% reduction in cancer, what are the potential increases
in side effect? [Above Median]
. . .that’s scary, whether you take it or not, take the pill, right, or not, it’s not a guarantee, the side effects
are worse than cancer. [Below Median]
Clinical Situation
Examples
PSA – 25% of participants asked at least one risk/benefit question following the PSA vignette (Women:
25%; Men: 25%).
. . .if I do have a PSA test and I either get a positive or a false positive, do you recommend a biopsy? Is
there any downside in getting a biopsy? [Above Median]
I would ask him. . .the prostate surgery. I would ask him about the sexual side effects, that would be
something, I guess that would stop a lot of guys from having it and that would probably be it. . .. [Below
Median]
Clinical Situation
Examples
CRC – 42% of participants asked at least one risk/benefit question following the CRC vignette. (Women:
43%; Men: 40%)
When he said rarely, but some side effects, well if you happened to do the colonoscopy and you do get
the tearing or the bleeding what can be done or what do they do about that? Then he said that there are
pluses and minuses for both, what are they? Well, I got the minuses for the colonoscopy with the tearing
and the bleeding. But what are the pluses and minuses for the stool samples? [Above Median]
What are the chances of the colonoscopy tearing my lining? Um, and how accurate is that FIT, the stool
test, how accurate is it? Because I’m weighing my odds. . . [Below Median]
Function
Clarification and Details
53% of participants asked at least one clarification and details question (Women: 53%; Men: 53%)
Clinical Situation
Examples
Tamoxifen – 19% of participants asked at least one clarification and details question following the
tamoxifen vignette. (Women: 17%; Men: 21%)
When would I have to start the medication? What would happen if I wanted to continue further than the
5 years which he said was the duration of the prescription? How would I be screened for the side effects?
[Above Median]
. . .Is there any time where can you take it for 1 year and then stop or if there is a reaction to these pills
like they said what do you do after that?. . . [Below Median]
Clinical Situation
Examples
PSA – 19% of participants asked at least one clarification and details question following the PSA vignette.
(Women: 19%; Men: 20%)
How long does it take to get results from the blood test? If it were positive it might be painful and I would
like to have that explained exactly what do they do that’s so painful? [Above Median]
. . .when you get the PSA test results, is there a number that indicates a high PSA number or a low PSA
number, or is it just. . . how do you tell how high your score is? Like is the higher the PSA number is, is it
the more likely you have prostate cancer? How frequently do you take the PSA test? Like every year or if
you decide not to have the biopsy, like if your PSA result is high like if you want to just retake it, does
your number fluctuate between the time you retake and 6 months to a year from now? [Below Median]
Clinical Situation
Examples
CRC – 34% of participants asked at least one clarification and details question following the CRC vignette.
(Women: 35%; Men:32%)
What kind of sedative. . .what kind of anesthesia whatever. . .would I be given for the procedure? How
long would the procedure last? What happens if polyps are found? [Above Median]
Well I guess if it’s the first time, I guess I would wanna know how long it’s gonna affect me; as far as if
there’s a discomfort or hurt. And if you find something when you do it, are you gonna go ahead and try to
get the samples then? Or later? How bad is the stuff gonna taste you’re gonna give me to take? [Below
Median]
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Table 3. Continued
Function
Applying Information to One’s Personal Situation
56% of participants asked at least one question that applied information to their personal situation
(Women: 55%; Men: 57%)
Clinical Situation
Examples
Tamoxifen – 28% of participants asked at least one question that applied information to their personal
situation following the tamoxifen vignette. (Women: 33%; Men:23%)
Where could I get more information about the drug and about breast cancer. . ..and more information as I
age? She’s 48 and she said for 5 years but he said as she gets older their odds go up getting it. So what
are my odds at 60? . . . [Above Median]
what is my risk of catching, of getting breast cancer? How often should I be checked if I’m at high risk? Are
there things I can do to prevent, you know, my risk of getting breast cancer? Do you, if someone in your
family has breast cancer does that mean that I will fall into that same category? [Below Median]
Clinical Situation
Examples
PSA – 27% of participants asked at least one question that applied information to their personal situation
following the PSA vignette. (Women:22%; Men: 34%)
What’s the likelihood of me having cancer based on my specific age? . . . [Above Median]
. . .what would his feelings about getting the test – at my condition, my age and you being my doctor,
what decision is best? [Below Median]
Clinical Situation
Examples
CRC – 23% of participants asked at least one question that applied information to their personal situation
following the CRC vignette. (Women: 22%; Men: 25%)
I guess I would want a little more understanding about the chances of getting colon cancer. Just given
what he knows about my history and lifestyle or whatever. [Above Median]
. . .why do I have to get tested for that, and am I at risk? . . .if it runs in my family, and if not why do I have
to take the test, or should I take it? Is it common in women, mostly, or is it men, like how common is colon
cancer for women? [Below Median]
Function
Information Beyond that Discussed
46% of participants asked at least one question about information beyond that discussed (Women: 44%;
Men: 48%)
Clinical Situation
Examples
Tamoxifen – 28% of participants asked at least one question about information beyond that discussed
following the tamoxifen vignette. (Women: 27%; Men: 29%)
How long has the drug been in use? Are there research studies that have been gathered from clinical
trials and what not? Where can I read more about tamoxifen? Are there other options? How long would I
probably have to take it? And so what are the statistics involving the side effects? I’ve heard that you
could have your breasts removed, and is that a viable option for me at my age and with my level of risk?
[Above Median]
If there is anything I could do outside of taking medication. . .like changing my diet or are there things that
I should avoid to keep from getting breast cancer other than medication. [Below Median]
Clinical Situation
Examples
PSA – 20% of participants asked at least one question about information beyond that discussed following
the PSA vignette. (Women: 20%; Men:21%)
I probably want to find out if there are any other tests on the horizon, you know, with the genetic stuff
that’s happening now right now, whether they are developing any additional tests for prostate cancer,
and if so I’d want to wait until those tests came out since prostate cancer grows so slowly. [Above
Median]
. . . Well I would ask him if is there anything we can do to continue it to be a slow growth such as dietary
restraints or such as some type of exercise or some type of physical exercise in order to keep it at a slow
growth rate or staying away from alcohol or something like that. . . [Below Median]
Clinical Situation
Examples
CRC – 16% of participants asked at least one question about information beyond that discussed following
the CRC vignette (Women:15%; Men: 17%)
He just mentioned the colonoscopy or whatever and the blood tests. But, I thought there were other
options, like that that sigmoidosocpy, flexible sigmoidoscopy. I would ask him if there were other
procedures. . . [Above Median]
I’d ask him is that a certain age people breakdown at 50 years old? [Below Median]
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types (SD = 1.3), and the mean for those scoring
above the median was 3.17 (SD = 1.5). The total
number of question subfunctions utilized also
did not diﬀer signiﬁcantly between the two
groups; a mean of 5.2 subfunctions (SD = 2.9)
were utilized by those scoring below the median
compared to 5.6 (SD = 3.4) by those scoring
above the median (P > 0.05). Comparisons
using the lower cut score (i.e. the bottom quar-
tile) also found no statistically signiﬁcant
diﬀerences between the two groups on these
measures (P > 0.05). Comparisons of these two
measures for women and men identiﬁed no sta-
tistically signiﬁcant diﬀerences (P > 0.05).
Table 3. Continued
Function
Locus of Decision Making
52% of participants asked at least one question about decision making (Women: 54%; Men: 50%)
Clinical Situation
Examples
Tamoxifen – 20% of participants asked at least one question about decision making following the
tamoxifen vignette. (Women: 21%; Men: 18%)
. . . I would ask him what would he recommend after giving me all this information? I would say I would
want to think about what you told me. When I’m impacted with a lot of information, I don’t like to make
snap decisions. I would ask him if it’s ok if I can think about it for a while, if it’s ok that I don’t tell you
right now what I want to do. [Above Median]
What does he recommend? [Below Median]
Clinical Situation
Examples
PSA – 35% of participants asked at least one question about decision making following the PSA vignette.
(Women: 35%; Men: 35%)
I would ask him if he really thinks I should have the test, and if I do have a positive reading, what should I
go from there, what should I do? . . . [Above Median]
. . . I would ask if there was literature available. . . I would get myself educated before I made another
appointment and made any further decisions. I’d write down all my questions after I did my reading.
[Below Median]
Clinical Situation
Examples
CRC – 18% of participants asked at least one question about decision making following the CRC vignette.
(Women: 19%; Men: 16%)
. . .I guess I might wonder what was the evidence-based recommendation for screening; method of
screening? What has the best. . .as opposed to asking what he would recommend, I’d say what is the
general recommendation because that’s based on studies. [Above Median]
Which would he recommend; the colonoscopy or the fecal sample? [Below Median]
Function
Credibility
35% of participants asked at least one question about credibility (Women: 37%; Men: 32%)
Clinical Situation
Examples
Tamoxifen – 12% of participants asked at least one question about credibility following the tamoxifen
vignette. (Women: 11%; Men: 13%)
That pill doesn’t deserve to be around. Good for the drug company and that’s it. [Above Median]
What is your success rate in preventing breast cancer using tamoxifen? [Below Median]
Clinical Situation
Examples
PSA – 14% of participants asked at least one question about credibility following the PSA vignette.
(Women: 15%; Men: 12%)
. . . It seemed like he doesn’t know what he’s saying. He doesn’t know what to say. He’s saying all kind of
things that are contradictory. So he has to chose. . .It doesn’t give me confidence in him. . .I could
probably google it and get the same information he just told me. . . .I don’t trust him already. [Above
Median]
I would be almost tempted to ask him to decide which side of his mouth he was talking out of because it
was like listening to a monologue by two different people; one who was encouraging you to get the test
and the other one who is at the same time discouraging you from getting it. [Below Median]
Clinical Situation
Examples
CRC – 17% of participants asked at least one question about credibility following the CRC vignette.
(Women:18%; Men: 15%)
He was pretty clear about the procedure so I don’t know if I would. . .And I’d probably ask if there’s
someone who’s done the procedure a lot, try to get somebody that’s skilled at it. [Above Median]
Why wasn’t he forthcoming on preparation and the patient was asking the preparation? He ignored that
altogether, until she asked. [Below Median]
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Table 4 presents results reﬂecting the variety
of question subtypes used within each question
function. Participants scoring above the median
on the CMLT-Listening tended to ask a greater
variety of questions related to risks and beneﬁts
across the three vignettes than participants
scoring below the median. This eﬀect was signiﬁ-
cant after adjusting for education using a
linear regression model. When both education
and the dichotomous variable based on the
CMLT-Listening median split were entered into
the equation, only the coeﬃcient for CMLT-
Listening variable was statistically signiﬁcant
(P = 0.038); the P-value associated with the edu-
cation variable did not approach statistical
signiﬁcance (P = 0.37). The eﬀect size associated
with the CMLT-Listening (Cohen’s f2) was
0.020 and would be characterized as small. How-
ever, using the lower cut score, the diﬀerence
between groups on variety of risk/beneﬁt ques-
tions was not statistically signiﬁcant (P > 0.05).
In contrast, participants scoring below the med-
ian on the CMLT-Listening tended to ask a
greater variety of questions related to personal-
izing the information. Again, this eﬀect persisted
after adjusting for education in linear regression
models. When both education and the dichoto-
mous variable based on the CMLT-Listening
median split were entered into the equation,
only the coeﬃcient associated with the CMLT-
Listening variable was statistically signiﬁcant
(P = 0.002); the P-value associated with the edu-
cation variable was not signiﬁcant (P = 0.83).
The eﬀect size associated with the CMLT-
Listening was small (Cohen’s f2 = 0.0267).
Deﬁning the two groups using the lower cut
score also resulted in a statistically signiﬁcant
between-group diﬀerence (P = 0.002), and that
diﬀerence remained statistically signiﬁcant after
adjusting for education. When both education
and the dichotomous variable based on the
CMLT-Listening lower cut score were entered
into the equation, only the coeﬃcient CMLT-
Listening variable was statistically signiﬁcant
(P = 0.001); the P-value associated with educa-
tion variable was not (P = 0.90). Again, the
eﬀect size associated with the CMLT-Listening
was small (Cohen’s f2 = 0.0288).
No diﬀerences were found between partici-
pants with high and low CMLT-Listening scores
with respect to question variety on the other four
question functions; this was also true when the
lower cut score was used. All P-values for these
comparisons were > 0.05.
No statistically signiﬁcant diﬀerences between
men and women were detected on the variety of
question subtypes used within each question
function; all P-values associated with these inde-
pendent t-tests were > 05.
Discussion
The ﬁndings from this study suggest that most
patients, regardless of listening health literacy
level, are willing and able to generate questions
about cancer prevention and screening when
prompted to do so. Further, the overall variety
of questions generated – that is, the number of
diﬀerent functions that participants’ questions
addressed – did not vary across the two groups.
These ﬁndings suggest that low and high listen-
ing health literacy patients share many of the
Table 4 Variety in question-asking: average percentage of subfunctions used
Question function
Participants with
CMLT-Listening scores
Below the median
(N = 215)
Participants with
CMLT-Listening scores
Above the median
(N = 218)
t-test
P-value
Risks and benefits 9.8% 12.6% 0.005
Details of the medical procedures 8.8% 10.2% –
Applying information to one’s personal situation 7.3% 4.9% 0.001
Information external to the doctor’s discourse 5.1% 6.0% –
Locus and timing of decision making 5.3% 5.6% –
Source credibility 5.1% 6.0% –
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same uncertainties when faced with decisions
about cancer prevention and screening, and both
harbour similar categories of questions.
While we found considerable similarities
across high and low listening health literacy
participants, we did ﬁnd two important and
statistically signiﬁcant diﬀerences. First, we
found that higher literacy participants (as opera-
tionalized by the CMLT-Listening test), relative
to their lower literacy counterparts, tended to
ask a greater variety of questions focused on the
risk and beneﬁts of the procedure or medication
under consideration. This ﬁnding is consistent
with studies linking low health literacy with poor
appreciation of health risk analyses,40 and sug-
gests that it may be helpful for providers to
prompt lower literacy patients to seek out and
consider general risk/beneﬁt information about
cancer screening or prevention, as they are less
likely to spontaneously request it.41 On the other
hand, higher listening health literacy patients
may desire rich information about risk/beneﬁt
analyses; messages well adapted to this group
therefore would oﬀer more extensive risk
information. Because identifying patients who
are at lower literacy levels may be challenging
for clinicians,42 it may be helpful for clinicians
to be trained in methods for eliciting
questions from all patients, as has been sug-
gested previously.43,44
Second, we found that lower listening health
literacy participants tended to ask a greater vari-
ety of questions seeking to personalize the
information, compared to higher literacy partici-
pants. This ﬁnding persisted across two diﬀerent
cut scores, as well as after adjusting for educa-
tion using linear regression. Rather than seeking
general information about cancer screening and
prevention, lower listening health literacy
patients desired information that was directly
tailored to their particular circumstances,
including their personal and family health histo-
ries. Thus, while higher literacy participants
asked questions like, ‘How often does a faecal
exam miss ﬁnding a real case of cancer?’, lower
literacy participants were more likely to ask, ‘If
my stool sample is clear of cancer, do I still have
to do the colonoscopy?’ This intriguing ﬁnding
has several potential explanations that call for
further research. One possibility is that low
literacy individuals have greater diﬃculty under-
standing probability estimates or the concept of
chance, or that low- and high-literacy individu-
als rely on diﬀerent interpretations of
probability. For example, in a study of patients
with cancer considering participation in phase I
trials, Weinfurt et al.45 found that patients with
less education endorsed belief-type interpreta-
tions of probability estimates ‘The doctor is
40% conﬁdent that the treatment will control
my cancer’, while patients with greater education
endorsed frequency-type interpretations (e.g.
‘For every 100 patients like me, the treatment
will work for 40 patients’). More research is
needed to test these and alternative explanations of
our ﬁndings, and to determine ways to help lower
literacy patients understand how information about
a decision applies to their individual circumstances.
The six major question-function categories,
applicable across all three vignettes, provide new
insights into what considerations and topics are
most salient to patients when they think about
cancer prevention and screening. Overall, ques-
tions related to understanding the risks and
beneﬁts of the procedure were most broadly uti-
lized. As shown in Table 3, 70% of participants
asked at least one question about risks/beneﬁts.
Not surprisingly, for example, a substantial
number of participants asked about tamoxifen
side-eﬀects, or questioned whether the risk
reduction obtained with tamoxifen would out-
weigh the risks of serious side-eﬀects, consistent
with ﬁndings reported previously regarding
patients’ decision making about tamoxifen pro-
phylaxis.46–49 Risk-/beneﬁt-related questions for
PSA testing tended to focus on the prevalence of
prostate cancer or false-positive or false-negative
errors associated with PSA testing. Risk/beneﬁt
questions for CRC screening tended to focus
on the advantages and disadvantages of the
diﬀerent screening methods, and their associ-
ated risks.
Also noteworthy in the descriptive data con-
veyed in Table 3 is the ﬁnding that questioning
about the risks and beneﬁts of PSA screening,
the intervention with the greatest associated sci-
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entiﬁc uncertainty, was relatively infrequent,
compared to tamoxifen use or CRC screening.
The percentage of participants asking risk/bene-
ﬁt questions after each vignette was 25%, 46%
and 42% for PSA, tamoxifen and CRC screen-
ing, respectively. On the other hand, questions
about the locus of decision making were most
highly utilized following the PSA discussion.
The percentage of participants asking questions
about the locus of decision making following
each vignette was 35%, 20% and 18% for PSA,
tamoxifen and CRC screening, respectively.
Many participants responded to the PSA
vignette by seeking an opinion or direct recom-
mendation from the physician, and several
expressed dissatisfaction that the physician in
the vignette did not oﬀer more directive advice.
This pattern of attempting to defer to the physi-
cian’s judgment is consistent with the high levels
of uncertainty surrounding PSA discussions.
Not surprisingly, participants were more
likely to ask procedure-related questions after
the CRC screening conversation, compared to
the tamoxifen and PSA screening conversations.
Colonoscopy procedure requires patients to pre-
pare themselves ahead of time, and many
questions focused on that preparation and sub-
sequent return to routine. Usage of questions
related to personalizing the information was rel-
atively similar across the three cancer vignettes;
in all three scenarios, participants sought infor-
mation on how the information would apply to
them, with their particular characteristics or his-
tory. As mentioned above, however, seeking out
personalized information of this nature was
most pronounced among participants who
exhibited low health literacy.
It is noteworthy that the measure of health lit-
eracy that distinguished question generating
preferences between people with high and low
levels of health literacy was based on oral com-
munication. Measurement of health literacy has
become a major pre-occupation, but most mea-
sures remain reading-based.50 The CMLT-
Listening is one of a small and relatively recent
set of instruments that acknowledges the pri-
macy of clinical information transmission
through oral interaction, and so would be
expected to be more strongly related to informa-
tion exchange in clinical encounters than
conventional reading-based instruments.
This study had limitations. First, participants
were reacting to a simulated rather than an
actual conversation in which they were partici-
pating. While there are advantages to this
approach (i.e. the presentation was standard-
ized), there are also disadvantages in that
participants had no opportunity to actually
interact with the physician and were not given
an opportunity to ask questions until the end of
the conversation. Further, the psycho-social
inﬂuences which may serve to inhibit or facilitate
question-asking diﬀered from those in actual
clinical encounters. It is possible that partici-
pants felt more able to ask questions in this
study, as some inhibiting factors, such as time
pressure on the physician, were not present, and
that such inhibiting eﬀects might interact with
health literacy in real encounters. In addition,
the use of simulation precluded exploration of
whether physician–patient concordance in terms
of gender, race, ethnicity or socio-economic
position aﬀected question-asking, an important
but unanswered question. Our use of this simu-
lated situation may have resulted in more
question-asking than would have occurred in an
actual encounter, as we explicitly encouraged
question-asking. Use of analogue patients in
research on clinical communication is quite com-
mon and, while diﬀerent from actual patients in
live encounters, can yield valuable insights.36,37
However, we were not able to explore additional
research investigating the role of the factors in
this study (such as whether lower literacy
patients are more inhibited in real encounters),
and it is clearly needed. We also note that the
CMLT-Listening, our measure of health liter-
acy, was administered at an earlier study session.
At present, there is no information available on
the stability of CMLT-Listening scores over
time. As in any study where volunteers are
recruited, it is not known how representative
these participants’ responses are with respect to
the general population. For example, many
study participants had a college education,
suggesting that this sample was more educated
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than the population overall. A ﬁnal, but impor-
tant, limitation is the absence of a measure of
prior knowledge about the three interventions
discussed in the vignettes.
One of the key issues that has emerged in the
ﬁeld of health messaging pertains to the relative
merits of tailoring information to relevant
patient individual diﬀerences,51 as opposed to
utilizing a, ‘universal precautions’52 approach in
health messages. Thus, for example, some stud-
ies oﬀer limited support for providing detailed
statistics about cancer screening and prevention
to persons exhibiting pronounced ‘need for cog-
nition’.53 In contrast, the trend in health literacy
practices leans towards creating messages that
can be easily processed by individuals with lim-
ited health literacy, in part because of the
diﬃculty of accurately screening patients’
health literacy levels in clinical settings.54 Some
have argued, however, that certain health liter-
acy practices, when applied universally, can
actually deprive consumers and patients of risk
information they might wish to know.55
Clearly, more research is needed to determine
optimum practices for increasing patient
question-asking in decision making and to
examine the eﬀects of training providers in
best practices.
Conclusion
Patient question-asking is a critical component
of both patient engagement and health literacy,
and a prerequisite to shared decision making.
This study provides insight into the types of
questions patients may have when presented
with information about three cancer prevention
and screening decisions. The greater variety of
personalizing questions asked by patients
with lower health literacy-listening scores is
intriguing and warrants replication and fur-
ther exploration.
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